Back to Results
First PageMeta Content
Antidotes / Chelating agents / Pharmacology / Deferiprone / Pharmacy / Thalassemia / Formulary / Deferasirox / Deferoxamine / Medicine / Chemistry / Health


Microsoft Word - e_hs0624cb2-2737-e.doc
Add to Reading List

Document Date: 2008-09-05 03:55:22


Open Document

File Size: 128,20 KB

Share Result on Facebook

Company

Hind Wing Co. Ltd. / PL/HS LC / /

Country

United States / Australia / United Kingdom / /

Currency

USD / /

Event

FDA Phase / /

Facility

University of Hong Kong / Queen Mary Hospital / Hospital Authority / /

IndustryTerm

present healthcare system / injection site / healthcare financing arrangements / supplementary healthcare financing / healthcare reform / healthcare / healthcare service reforms / healthcare system / public healthcare safety net / health insurance / public healthcare / clear clinical protocols / healthcare reforms / /

MedicalCondition

bone deformity / pre-existing diseases / agranulocytosis / neutropenia / severe joint pain / rare disorders / /

MedicalTreatment

clinical protocols / drug therapy / /

Organization

Exjade / Italian Society of Hematology / Mary Hospital / Ms Amy YU Senior Council / LEE Pak-wai Chief Pharmacist Hospital Authority / Mary SO Chief Council / International Thalassaemia Federation / US Food and Drug Administration / Food and Health Bureau / Thalassaemia Association of Hong Kong / University of Hong Kong / European Union / Queen Mary Hospital / Children's Thalassaemia Foundation / /

Person

Sophie / Hon Joseph / Hon Fernando / /

Position

JP Director / HA Shau-yin Consultant / Department of Paediatrics and Adolescent Medicine / Sandy HAU Legislative Assistant / Chief Executive / Pharmacist / Clerk / Beatrice CHENG Chief Manager / Consultant / General / Secretary / Deputy Secretary / Director Ms SIU / Chairman / Director / Chief Manager / forward the service / Gloria LO Principal Assistant Secretary / Consultant / Department of Paediatrics and Adolescent Medicine / LEUNG Ka-fai Chairman / Representative / Deputy Chairman / Director / Deputy Chairman / WONG Hang-yue Director / /

Product

Exjade / Deferiprone / /

Technology

LAN / clear clinical protocols / /

SocialTag